Clinical Trial Update: Continuation of the nuMoM2b Heart Health Study

View source ↗

Summary

The nuMoM2b Heart Health Study is continuing enrollment by invitation in a cardiovascular disease study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: RTI International | Conditions: Cardiovascular Diseases | Status: ENROLLING_BY_INVITATION